BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25296841)

  • 1. Early oligomerization stages for the non-amyloid component of α-synuclein amyloid.
    Eugene C; Laghaei R; Mousseau N
    J Chem Phys; 2014 Oct; 141(13):135103. PubMed ID: 25296841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and thermodynamics of amylin dimer studied by Hamiltonian-temperature replica exchange molecular dynamics simulations.
    Laghaei R; Mousseau N; Wei G
    J Phys Chem B; 2011 Mar; 115(12):3146-54. PubMed ID: 21384830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study.
    Park S; Yoon J; Jang S; Lee K; Shin S
    J Biomol Struct Dyn; 2016; 34(2):376-83. PubMed ID: 25869255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and thermodynamics of Alzheimer's amyloid-beta Abeta(16-35) monomer and dimer by replica exchange molecular dynamics simulations: implication for full-length Abeta fibrillation.
    Chebaro Y; Mousseau N; Derreumaux P
    J Phys Chem B; 2009 May; 113(21):7668-75. PubMed ID: 19415895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid beta(Abeta) and alpha-synuclein fragment peptide (NAC).
    Kuroda Y; Maeda Y; Hanaoka H; Miyamoto K; Nakagawa T
    J Pept Sci; 2004 Jan; 10(1):8-17. PubMed ID: 14959887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model amyloid peptide B18 monomer and dimer studied by replica exchange molecular dynamics simulations.
    Knecht V
    J Phys Chem B; 2010 Oct; 114(39):12701-7. PubMed ID: 20839866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation.
    Lorenzen N; Nielsen SB; Buell AK; Kaspersen JD; Arosio P; Vad BS; Paslawski W; Christiansen G; Valnickova-Hansen Z; Andreasen M; Enghild JJ; Pedersen JS; Dobson CM; Knowles TP; Otzen DE
    J Am Chem Soc; 2014 Mar; 136(10):3859-68. PubMed ID: 24527756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular simulations of the fluctuating conformational dynamics of intrinsically disordered proteins.
    Smith WW; Schreck CF; Hashem N; Soltani S; Nath A; Rhoades E; O'Hern CS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Oct; 86(4 Pt 1):041910. PubMed ID: 23214618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational characteristics of unstructured peptides: alpha-synuclein.
    Yoon J; Park J; Jang S; Lee K; Shin S
    J Biomol Struct Dyn; 2008 Apr; 25(5):505-15. PubMed ID: 18282005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact between the β1 and β2 Segments of α-Synuclein that Inhibits Amyloid Formation.
    Shaykhalishahi H; Gauhar A; Wördehoff MM; Grüning CS; Klein AN; Bannach O; Stoldt M; Willbold D; Härd T; Hoyer W
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8837-40. PubMed ID: 26119103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural diversity of the soluble trimers of the human amylin(20-29) peptide revealed by molecular dynamics simulations.
    Mo Y; Lu Y; Wei G; Derreumaux P
    J Chem Phys; 2009 Mar; 130(12):125101. PubMed ID: 19334894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the disulfide bond on the monomeric structure of human amylin studied by combined Hamiltonian and temperature replica exchange molecular dynamics simulations.
    Laghaei R; Mousseau N; Wei G
    J Phys Chem B; 2010 May; 114(20):7071-7. PubMed ID: 20429571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of secondary structure propensities to sequence differences between alpha- and gamma-synuclein: implications for fibrillation.
    Marsh JA; Singh VK; Jia Z; Forman-Kay JD
    Protein Sci; 2006 Dec; 15(12):2795-804. PubMed ID: 17088319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of all-atom force fields on amyloid oligomerization: replica exchange molecular dynamics simulations of the Aβ(16-22) dimer and trimer.
    Nguyen PH; Li MS; Derreumaux P
    Phys Chem Chem Phys; 2011 May; 13(20):9778-88. PubMed ID: 21487594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation studies on the stabilities of aggregates formed by fibril-forming segments of alpha-Synuclein.
    Yoon J; Jang S; Lee K; Shin S
    J Biomol Struct Dyn; 2009 Dec; 27(3):259-70. PubMed ID: 19795910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation.
    Sanjeev A; Sahu RK; Mattaparthi VSK
    J Biomol Struct Dyn; 2017 Nov; 35(15):3342-3353. PubMed ID: 27809690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.